Skip to Main Content

Author Details

David S K Lu
University of California, Los Angeles David Geffen School of Medicine
1990
162
44
PMIDPaper TitleJournal TitlePublished Year
36169546Hepatocellular Adenoma Subtypes Based on 2017 Classification System: Exploratory Study of Gadoxetate Disodium-Enhanced MRI Features With Proposal of a Diagnostic Algorithm.AJR Am J Roentgenol2023
37665139Combination transarterial chemoembolization and microwave ablation vs. microwave ablation monotherapy for hepatocellular carcinomas greater than 3 cm: a comparative study.Diagn Interv Radiol2023
37399400Comprehensive tissue deconvolution of cell-free DNA by deep learning for disease diagnosis and monitoring.Proc Natl Acad Sci U S A2023
36853392Contrast-enhanced ultrasound for abdominal image-guided procedures.Abdom Radiol (NY)2023
36716121MR imaging biomarkers in HCC: outcomes correlation in liver transplant listed patients.Clin Transplant2023
36821508Hepatocellular Adenomas: Molecular Basis and Multimodality Imaging Update.Radiographics2023
34689252Steady-state ferumoxytol-enhanced MRI: early observations in benign abdominal organ masses and clinical implications.Abdom Radiol (NY)2022
35544375Beyond the <i>AJR</i>: The Emerging Role of Radiofrequency Ablation in the Treatment of Low-Risk Papillary Microcarcinoma of the Thyroid.AJR Am J Roentgenol2022
35671135Read-out Segmented Echo Planar Imaging with Two-Dimensional Navigator Correction (RESOLVE): An Alternative Sequence to Improve Image Quality on Diffusion-Weighted Imaging of Prostate.Br J Radiol2022
35536392Correction to: CT-monitored minimal ablative margin control in single-session microwave ablation of liver tumors: an effective strategy for local tumor control.Eur Radiol2022
35396970Safety of percutaneous, image-guided biopsy of hepatocellular carcinoma with and without concurrent ablation.Abdom Radiol (NY)2022
35389047CT-monitored minimal ablative margin control in single-session microwave ablation of liver tumors: an effective strategy for local tumor control.Eur Radiol2022
35328166Use of U-Net Convolutional Neural Networks for Automated Segmentation of Fecal Material for Objective Evaluation of Bowel Preparation Quality in Colonoscopy.Diagnostics (Basel)2022
34662702Free-breathing 3D stack-of-radial MRI quantification of liver fat and R<sub>2</sub>* in adults with fatty liver disease.Magn Reson Imaging2022
33392733Histogram-based analysis of cerebral blood flow using arterial spin labeling MRI in de novo brain gliomas: relationship to histopathologic grade and molecular markers.Neuroradiology2021
33908801Optimizing Spatial Biopsy Sampling for the Detection of Prostate Cancer.J Urol2021
33608192Image-Guided Percutaneous Thermal Ablation of Oligometastatic Ovarian and Non-Ovarian Gynecologic Tumors.J Vasc Interv Radiol2021
34966854Nonalcoholic fatty liver disease-related hepatocellular carcinoma growth rates and their clinical outcomes.Hepatoma Res2021
31549211Dynamic contrast-enhanced (DCE) MR imaging: the role of qualitative and quantitative parameters for evaluating prostate tumors stratified by Gleason score and PI-RADS v2.Abdom Radiol (NY)2020
31642698Cirrhotic Nodule Transformation to Hepatocellular Carcinoma: Natural History and Predictive Biomarkers on Contrast-Enhanced Ultrasound.AJR Am J Roentgenol2020
31900708Updated 10-year outcomes of percutaneous radiofrequency ablation as first-line therapy for single hepatocellular carcinoma &lt;⿿3 cm: emphasis on association of local tumor progression and overall survival.Eur Radiol2020
31822975Percutaneous thermal ablation of subcapsular hepatocellular carcinomas: influence of tumor-surface contact and protrusion on therapeutic efficacy and safety.Eur Radiol2020
31767409Long-Term Survival after Percutaneous Radiofrequency Ablation of Pathologically Proven Renal Cell Carcinoma in 100 Patients.J Vasc Interv Radiol2020
32676870Automatic needle tracking using Mask R-CNN for MRI-guided percutaneous interventions.Int J Comput Assist Radiol Surg2020
327551663-T Multiparametric MRI Followed by In-Bore MR-Guided Biopsy for Detecting Clinically Significant Prostate Cancer After Prior Negative Transrectal Ultrasound-Guided Biopsy.AJR Am J Roentgenol2020
32921565Efficacy of 3T Multiparametric MR Imaging followed by 3T in-Bore MR-Guided Biopsy for Detection of Clinically Significant Prostate Cancer Based on PIRADSv2.1 Score.J Vasc Interv Radiol2020
32130048Influence of the Location and Zone of Tumor in Prostate Cancer Detection and Localization on 3-T Multiparametric MRI Based on PI-RADS Version 2.AJR Am J Roentgenol2020
30273608Three Tesla Multiparametric Magnetic Resonance Imaging: Comparison of Performance with and without Endorectal Coil for Prostate Cancer Detection, PI-RADSâ¿¢ version 2 Category and Staging with Whole Mount Histopathology Correlation.J Urol2019
31361529Utility of Multiparametric MRI for Predicting Residual Clinically Significant Prostate Cancer After Focal Laser Ablation.AJR Am J Roentgenol2019
31039011Utility of Restriction Spectrum Imaging Among Men Undergoing First-Time Biopsy for Suspected Prostate Cancer.AJR Am J Roentgenol2019
30995090Detection and Localization of Prostate Cancer at 3-T Multiparametric MRI Using PI-RADS Segmentation.AJR Am J Roentgenol2019
30847565The effect of tumor size and location on efficacy and safety of US- and CT- guided percutaneous microwave ablation in renal cell carcinomas.Abdom Radiol (NY)2019
31162060In Regard to Jackson et al.Int J Radiat Oncol Biol Phys2019
30460528Characteristics of missed prostate cancer lesions on 3T multiparametric-MRI in 518 patients: based on PI-RADSv2 and using whole-mount histopathology reference.Abdom Radiol (NY)2019
30509763Detection of Individual Prostate Cancer Foci via Multiparametric Magnetic Resonance Imaging.Eur Urol2019
30588756Noninvasive Assessment of Hepatocellular Carcinoma Tumor Thrombus: Is It All in Vein?Liver Transpl2019
30441889Radiomics and radiogenomics of primary liver cancers.Clin Mol Hepatol2019
29479728An expert consensus for the management of chronic hepatitis B in Asian Americans.Aliment Pharmacol Ther2018
29995500Liver MR Elastography at 3 T: Agreement Across Pulse Sequences and Effect of Liver R2* on Image Quality.AJR Am J Roentgenol2018
30013957Percutaneous Radiofrequency Ablation of Small (1-2â¿¿cm) Hepatocellular Carcinomas Inconspicuous on B-Mode Ultrasonographic Imaging: Usefulness of Combined Fusion Imaging with MRI and Contrast-Enhanced Ultrasonography.Can J Gastroenterol Hepatol2018
29573187Propensity-Matched Analysis of Patients with Mixed Hepatocellular-Cholangiocarcinoma and Hepatocellular Carcinoma Undergoing Liver Transplantation.Liver Transpl2018
29460041Building a high-resolution T2-weighted MR-based probabilistic model of tumor occurrence in the prostate.Abdom Radiol (NY)2018
27861110In-Bore 3-T MR-guided Transrectal Targeted Prostate Biopsy: Prostate Imaging Reporting and Data System Version 2-based Diagnostic Performance for Detection of Prostate Cancer.Radiology2017
28170115Radiofrequency ablation of hepatocellular carcinoma as bridge therapy to liver transplantation: A 10-year intention-to-treat analysis.Hepatology2017
28177652Irreversible Electroporation: Defining the MRI Appearance of the Ablation Zone With Histopathologic Correlation in a Porcine Liver Model.AJR Am J Roentgenol2017
29404481Long-term survival after surveillance and treatment in patients with chronic viral hepatitis and hepatocellular carcinoma.Hepatol Commun2017
28858541Risk Stratification Among Men With Prostate Imaging Reporting and Data System version 2 Category 3 Transition Zone Lesions: Is Biopsy Always Necessary?AJR Am J Roentgenol2017
28688158Determination of hepatocellular carcinoma grade by needle biopsy is unreliable for liver transplant candidate selection.Liver Transpl2017
27875639Longterm follow-up of small pancreatic cystic lesions in liver transplant recipients.Liver Transpl2017
27977329Reducing Artifacts during Arterial Phase of Gadoxetate Disodium-enhanced MR Imaging: Dilution Method versus Reduced Injection Rate.Radiology2017
  • 1 - 50 of 162

Recommended Authors

Kyungmouk Steve Lee
New York Presbyterian Hospital Weill Cornell Medicine
Career Start Year 2013
Number of shared co-authors 0
Jesse K Sandberg
Stanford University, Lucile Packard Children's Hospital
Career Start Year 2009
Number of shared co-authors 3
Scott Genshaft
University of California los angeles
Career Start Year 2008
Number of shared co-authors 9
Spencer C Behr
University of California san francisco
Career Start Year 2007
Number of shared co-authors 2
Thomas A Hope
University of California san francisco
Career Start Year 2007
Number of shared co-authors 2
Daniele Marin
Duke University Medical Center
Career Start Year 2004
Number of shared co-authors 0
Iva Petkovska
Memorial Sloan Kettering Cancer Center
Career Start Year 2004
Number of shared co-authors 5
Abhijit Sunnapwar
University of Texas Health San Antonio
Career Start Year 2004
Number of shared co-authors 0
Adam D Talenfeld
Weill Cornell Medical College
Career Start Year 2003
Number of shared co-authors 1
Andrew Scanga
Vanderbilt University Medical Center
Career Start Year 2003
Number of shared co-authors 0
Ahmed W Moawad
The University of Texas MD Anderson Cancer Center
Career Start Year 2003
Number of shared co-authors 0
Bhavik N Patel
Gold Coast University Hospital
Career Start Year 2002
Number of shared co-authors 0
Won Young Tak
Kyungpook National University
Career Start Year 2001
Number of shared co-authors 1
Bradley B Pua
Weill Cornell Medical Center, NewYork-Presbyterian Hospital
Career Start Year 2000
Number of shared co-authors 3
Gianpaolo Carrafiello
Foundation IRCCS Ca' Granda - Ospedale Maggiore Policlinico, University of Milan
Career Start Year 2000
Number of shared co-authors 2
Arief A Suriawinata
Dartmouth Hitchcock Medical Center
Career Start Year 1999
Number of shared co-authors 0
Krishna Juluru
Memorial Sloan Kettering Cancer Center
Career Start Year 1999
Number of shared co-authors 2
Alda L Tam
MD Anderson Cancer Center
Career Start Year 1998
Number of shared co-authors 4
Amit Rastogi
Institute of Liver Transplantation
Career Start Year 1996
Number of shared co-authors 0
Jeremy C Durack
Memorial Sloan Kettering Cancer Center
Career Start Year 1996
Number of shared co-authors 5
Richard K G Do
Memorial Sloan Kettering Cancer Center
Career Start Year 1996
Number of shared co-authors 1
Masoom A Haider
University Health Network
Career Start Year 1995
Number of shared co-authors 2
Oliver F Bathe
Cumming School of Medicine, University of Calgary
Career Start Year 1991
Number of shared co-authors 0
Elizabeth C Jones
Clinical Center, National Institutes of Health
Career Start Year 1989
Number of shared co-authors 1
Atsushi Nanashima
University of Miyazaki
Career Start Year 1988
Number of shared co-authors 0
Piet C de Groen
University of Minnesota
Career Start Year 1987
Number of shared co-authors 0
Richard D Schulick
University of Colorado School of Medicine
Career Start Year 1983
Number of shared co-authors 2
Peter L Choyke
National Cancer Institute, National Institutes of Health
Career Start Year 1982
Number of shared co-authors 12
Luis Ib????ez
Gregorio Maranon University Hospital
Career Start Year 1980
Number of shared co-authors 0
Zachary Goodman
Center for Liver Diseases, Inova Fairfax Hospital
Career Start Year 1975
Number of shared co-authors 2

Collaborators

Steven S Raman
University of California, Los Angeles David Geffen School of Medicine
Co-authored papers 100
James Sayre
David Geffen School of Medicine at university of california los angeles
Co-authored papers 38
Ely R Felker
University of California, Los Angeles David Geffen School of Medicine
Co-authored papers 22
Daniel J Margolis
Weill Cornell Medical College
Co-authored papers 14
Preeti Ahuja
David Geffen School of Medicine, University of California at Los Angeles
Co-authored papers 10
Nelly Tan
Department of Radiology at the Mayo Clinic Hospital in Phoenix
Co-authored papers 10
Anthony Sisk
University of California los angeles
Co-authored papers 8
Kyunghyun Sung
University of California los angeles
Co-authored papers 8
Robert E Reiter
David Geffen School of Medicine at university of california los angeles
Co-authored papers 7
Sohrab Afshari Mirak
University Hospitals Cleveland Medical Center/Case Western Reserve University
Co-authored papers 7
Nazanin H Asvadi
Saint Vincent Hospital
Co-authored papers 7
Pooria Khoshnoodi
University of Pittsburgh Medical Center
Co-authored papers 6
Holden H Wu
David Geffen School of Medicine, University of California Los Angeles
Co-authored papers 6
Vatche G Agopian
David Geffen School of Medicine , University of California los angeles
Co-authored papers 6
Amirhossein Mohammadian Bajgiran
David Geffen School of Medicine at university of california los angeles
Co-authored papers 6
Daniela Markovic
David Geffen School of Medicine at university of california los angeles
Co-authored papers 5
Jiaoti Huang
Duke University School of Medicine
Co-authored papers 5
Bita V Naini
university of california los angeles Medical Center
Co-authored papers 5
William Hsu
American Medical Informatics Association, IEEE, Johns Hopkins University, Radiological Society of North America, University of California Los Angeles, University of California, Los Angeles
Co-authored papers 4
Stephanie A Lee-Felker
David Geffen School of Medicine, University of California at Los Angeles
Co-authored papers 4
Steven-Huy B Han
David Geffen School of Medicine , University of California los angeles
Co-authored papers 4
William Hsu
Co-authored papers 4
Stuart G Silverman
Brigham and Women's Hospital, Harvard Medical School
Co-authored papers 3
Cleo K Maehara
University of California Los Angeles
Co-authored papers 3
Peter G Schulam
Yale University
Co-authored papers 3
Pornphan Wibulpolprasert
Ramathibodi Hospital
Co-authored papers 3
Juan Pablo Villablanca
David Geffen School of Medicine, University of California Los Angeles
Co-authored papers 2
Stephen B Solomon
Memorial Sloan-Kettering Cancer Center
Co-authored papers 2
Bradford J Wood
National Cancer Institute, National Institutes of Health
Co-authored papers 2
Elizabeth G McFarland
Center for Diagnostic Imaging
Co-authored papers 2
Release 1.2